HRT Financial’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-30,658
| Closed | -$126K | – | 2992 |
|
|
2024
Q1 | $126K | Sell |
30,658
-31,264
| -50% | -$128K | ﹤0.01% | 1725 |
|
|
2023
Q4 | $261K | Sell |
61,922
-221,882
| -78% | -$935K | ﹤0.01% | 1533 |
|
|
2023
Q3 | $1.23M | Buy |
+283,804
| New | +$1.23M | 0.01% | 789 |
|
|
2023
Q1 | – | Sell |
-53,627
| Closed | -$396K | – | 3044 |
|
|
2022
Q4 | $396K | Sell |
53,627
-76,158
| -59% | -$562K | 0.01% | 1445 |
|
|
2022
Q3 | $1.28M | Buy |
129,785
+71,692
| +123% | +$708K | 0.01% | 751 |
|
|
2022
Q2 | $633K | Buy |
+58,093
| New | +$633K | 0.01% | 1288 |
|
|
2022
Q1 | – | Sell |
-24,450
| Closed | -$383K | – | 3613 |
|
|
2021
Q4 | $383K | Buy |
+24,450
| New | +$383K | ﹤0.01% | 1879 |
|
|
2021
Q3 | – | Sell |
-17,571
| Closed | -$377K | – | 3549 |
|
|
2021
Q2 | $377K | Sell |
17,571
-12,655
| -42% | -$272K | ﹤0.01% | 1907 |
|
|
2021
Q1 | $453K | Buy |
+30,226
| New | +$453K | ﹤0.01% | 1675 |
|
|
2020
Q4 | – | Sell |
-11,279
| Closed | -$108K | – | 2435 |
|
|
2020
Q3 | $108K | Sell |
11,279
-17,003
| -60% | -$163K | ﹤0.01% | 1423 |
|
|
2020
Q2 | $323K | Buy |
+28,282
| New | +$323K | 0.01% | 850 |
|
|
2020
Q1 | – | Sell |
-15,174
| Closed | -$249K | – | 1287 |
|
|
2019
Q4 | $249K | Buy |
+15,174
| New | +$249K | 0.01% | 791 |
|
|
2015
Q3 | – | Sell |
-10,477
| Closed | -$132K | – | 187 |
|
|
2015
Q2 | $132K | Buy |
+10,477
| New | +$132K | 0.06% | 144 |
|